An emission model tracking the life cycle pathways of human pharmaceuticals in Korea

Environmental Health and Preventive Medicine

Volumn 19, Issue 1, 2014, Pages 46-55

  Han, Eun Jeong ^a   Kim, Hee Seok ^a   Lee, Dong Soo ^a  

^a Seoul National University   (South Korea)

Author keywords

Emission model; Pathway; Pharmaceuticals; Sensitivity; Uncertainty

Indexed keywords

CEFRADINE; IBUPROFEN; MEFENAMIC ACID; NAPROXEN; PARACETAMOL; SURFACE WATER;

ANALYTIC METHOD; ARTICLE; BIODEGRADATION; CONTROLLED STUDY; DRUG EXCRETION; EMISSION MODEL TRACKING; ENVIRONMENTAL PARAMETERS; KOREA; LIFE CYCLE STAGE; NONHUMAN; PHARMACOLOGICAL PROCEDURES; SCREENING; SENSITIVITY ANALYSIS; SEWAGE TREATMENT PLANT; SLUDGE; WASTE MANAGEMENT;

ENVIRONMENTAL MONITORING; HUMANS; MODELS, THEORETICAL; PHARMACEUTICAL PREPARATIONS; REPUBLIC OF KOREA; WATER POLLUTANTS, CHEMICAL;

EID: 84893715771     PISSN: 1342078X     EISSN: 13474715     Source Type: Journal    
DOI: 10.1007/s12199-013-0352-8     Document Type: Article

References (31)

1. Heberer T, Stan HJ. Determination of clofibric acid and N-(phenylsufonyl)-sarcosine in sewage, river and drinking water. Int J Environ Anal Chem. 1997;67(1-4):113-24.
2. Buser HR, Müller MD, Theobald N. Occurrence of the pharmaceutical drug clofibric acid and the herbicide mecoprop in various Swiss lakes and in the North Sea. Environ Sci Technol. 1998;32(1):188-92.
3. Buser HR, Poiger T, Müller MD. Occurrence and fate of the pharmaceutical drug diclofenac in surface waters: Rapid photodegradation in a lake. Environ Sci Technol. 1998;32(22):3449-56.
4. Daughton CG. Chemicals from the practice of healthcare: challenges and unknowns posed by residues in the environment. Environ Toxicol Chem. 2009;28(12):2490-4.
5. Rodriguez-Mozaz S, Weinberg HS. Meeting report: pharmaceuticals in water-an interdisciplinary approach to a public health challenge. Environ Health Perspect. 2010;118(7):1016-20.
6. Kim JW, Jang HS, Kim JG, Ishbashi H, Hirano M, Nasu K, et al. Occurrence of pharmaceutical and personal care products (PPCPs) in surface water from Mankyung River, South Korea. J Health Sci. 2009;55(2):249-58.
7. Choi K, Kim Y, Park J, Park CK, Kim M, Kim HS, et al. Seasonal variations of several pharmaceutical residues in surface water and sewage treatment plants of Han River, Korea. Sci Total Environ. 2008;405(1-3):120-8.
8. Choi K, Kim Y, Jung J, Kim MH, Kim CS, Kim NH, et al. Occurrences and ecological risks of roxithromycin, trimethoprim, and chloramphenicol in the Han river, Korea. Environ Toxicol Chem. 2008;27(3):711-9.
9. National Institute of Environmental Research, Korea (NIER). Development of analytical method and study of exposure of pharmaceuticals and personal care products in environment. 2006 (in Korean). NIER, Incheon.
10. National Institute of Environmental Research, Korea (NIER). Development of analytical method and study of exposure of pharmaceuticals and personal care products in environment (II). 2007 (in Korean). NIER, Incheon.
11. National Institute of Environmental Research, Korea (NIER). Environmental risk assessment of residual pharmaceuticals (I). 2008 (in Korean). NIER, Incheon.
12. National Institute of Environmental Research, Korea (NIER). Environmental risk assessment of residual pharmaceuticals (II). 2009 (in Korean). NIER, Incheon.
13. National Institute of Environmental Research, Korea (NIER). Environmental risk assessment of residual pharmaceuticals (III). 2010 (in Korean). NIER, Incheon.
14. Behera SK, Kim HW, Oh JE, Park HS. Occurrence and removal of antibiotics, hormones and several other pharmaceuticals in wastewater treatment plants of the largest industrial city of Korea. Sci Total Environ. 2011;409(20):4351-60.
15. U.S. Food and Drug Administration (FDA). Guidance for industry-environmental assessment of human drug and biologics applications. 1998. FDA, Washington D.C.
16. European Agency for the Evaluation of Medical Products. Guideline on the environmental risk assessment of medicinal products for human use. 2006. European Agency for the Evaluation of Medical Products, London.
17. Halling-Sørensen B, Nielsen SN, Lanzky PF, Ingerslev F, Lützhøft HCH, Jørgensen SE. Occurrence, fate and effects of pharmaceutical substances in the environment - a review. Chemosphere. 1998;36(2):357-93.
18. Koehler A, Wildbolz C. Comparing the environmental footprints of home-care and personal-hygiene products: the relevance of different life-cycle phases. Environ Sci Technol. 2009;43(22):8643-51.
19. Daughton CG, Ruhoy IS. Environmental footprint of pharmaceuticals: the significance of factors beyond direct excretion to sewers. Environ Toxicol Chem. 2009;28(12):2495-521.
20. National Institute of Environmental Research, Korea Republic. Development of analytical method and study of exposure of residual pharmaceuticals (II). 2009 (in Korean). NIER, Incheon.
21. Korea Pharmaceutical Manufacturers Association (KPMA). Pharmaceutical production in 2009. 2010 (in Korean). KPMA, Seoul.
22. Korea Pharmaceutical Information Center. Monograph. Available at: http://www.health.kr. Accessed 4 June 2012.
23. Druginfo. Monograph. Available at: http://www.druginfo.co.kr. Accessed 4 June 2012.
24. American Society of Health-System Pharmacists. AHFS DI monographs. Available at http://www.drugs.com/monograph. Accessed 4 June 2012.
25. Gentry B. Oracle crystal ball user manual, release 11.1.1.1.00. Oracle; 2008.
26. Korea Zero Waste Movement Network (KWMN). Proper usage of domestic pharmaceuticals and pilot project of pharmaceutical Take-Back program. 2009 (in Korean). KWMN, Seoul.
27. Korea Zero Waste Movement Network (KWMN). Proper usage of domestic pharmaceuticals and pilot project of pharmaceutical Take-Back program. 2010 (in Korean). KWMN, Seoul.
28. Korea Pharmaceutical Manufacturers Association (KPMA). Statistics of Pharmaceutical Industry. 2010 (in Korean). KPMA, Seoul.
29. Ministry of Environment, Korea. 2009 Statistics of sewerage. 2010 (in Korean). Ministry of Environment, Seoul.
30. Korea Zero Waste Movement Network (KWMN). Treatment method of pharmaceuticals disposed by pharmaceutical-using institutes. 2009 (in Korean). KWMN, Seoul. Available at: http://www.waste21.or.kr.
31. Cleuvers M. Mixture toxicity of the anti-inflammatory drugs diclofenac, ibuprofen, naproxen, and acetylsalicylic acid. Ecotoxicol Environ Saf. 2004;59(3):309-15.